It has been shown that elevated levels of PAX2 in CRC leads to an increase in the proliferative potential of the cells via activation of the transcription factor AP-1 and the JUN-FOS pathway causing the upregulation of cyclin D1, a protein involved in cell cycling (7, 15). The gene discussed is FOS; the disease is colorectal carcinoma.